XML 109 R88.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Financial Information of the Parent Company (Schedule of Statements of Cash Flows) (Details)
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2015
USD ($)
Dec. 31, 2015
CNY (¥)
Dec. 31, 2014
CNY (¥)
Dec. 31, 2013
CNY (¥)
STATEMENTS OF CASH FLOWS        
Cash (used in) provided by operating activities $ (79,462) ¥ (514,735) ¥ (271,102) ¥ 116,736
Cash flows used in investing activities (295,651) (1,915,168) (227,923) (304,218)
Cash flows from financing activities 464,022 3,005,838 1,540,397 306,360
Effect of exchange rate changes on cash 10,429 67,560 (3,053) 1,287
Net increase in cash and cash equivalents 99,338 643,495 1,038,319 120,165
Cash and cash equivalents at the beginning of year 25,034 1,457,722 419,403 299,238
Cash and cash equivalents at the end of year $ 324,372 ¥ 2,101,217 1,457,722 419,403
Supplemental disclosure of non-cash investing and financing activities        
Deemed dividends to preferred shareholders 15,606 ¥ 59,428
Accrued issuance cost related to private placement ¥ 14,076
Accrual related to deferred initial public offering costs ¥ 2,127
Receivables related to exercise of stock options $ (522) ¥ (3,379) ¥ (1,020)
Parent Company [Member]        
STATEMENTS OF CASH FLOWS        
Cash (used in) provided by operating activities 99,627 645,364 2,636 ¥ (3,058)
Cash flows used in investing activities (530,229) (3,434,719) (518,690) (93,595)
Cash flows from financing activities 377,113 2,442,860 1,540,397 306,360
Effect of exchange rate changes on cash 17,492 113,312 (3,040) (5,250)
Net increase in cash and cash equivalents (35,997) (233,183) 1,021,303 204,457
Cash and cash equivalents at the beginning of year 204,279 1,323,280 301,977 97,520
Cash and cash equivalents at the end of year $ 168,282 1,090,097 1,323,280 301,977
Supplemental disclosure of non-cash investing and financing activities        
Deemed dividends to preferred shareholders   15,606 ¥ 59,428
Accrued issuance cost related to private placement   ¥ 14,076
Accrual related to deferred initial public offering costs   ¥ 2,127
Receivables related to exercise of stock options $ (522) ¥ (3,379) ¥ (1,020)